AMSlab Group Expands Its Capabilities to Continue Growing from Lugo
There are moments in a company’s journey when different milestones come together to mark the beginning of a new chapter. After years of transformation and continuous growth, the AMSlab Group is taking a significant step forward with a renewed identity, enhanced capabilities, and a broader vision of its role in science and innovation.
This evolution is first reflected in the group’s new 3,000 m² headquarters, spread across three floors that integrate laboratories and administrative offices. Designed to meet the group’s current needs while preparing for the challenges of the years ahead, the new facilities feature state-of-the-art laboratories, expanded production areas, and collaborative workspaces that encourage interaction between teams, reflecting both the scale AMSlab has achieved and the direction in which it continues to grow.
However, AMSlab’s transformation goes far beyond a new visual identity or modern facilities. Over recent years, the group has significantly expanded its scope of activity to address the evolving needs of increasingly diverse and specialised industries.
One of the most significant milestones has been the launch of AMShealth, the group’s new company specialising in mass spectrometry-based analytical services for clinical research. Through AMShealth, the Group extends its expertise into the healthcare sector, providing analytical support to hospitals, clinics, laboratories, and research centres with solutions that contribute to more precise and personalised medicine.
The group’s commitment to innovation is also reflected in the development of new products. Through Cifga, the group’s reference materials laboratory, AMSlab has launched a new line of standards for the pharmaceutical industry, further expanding an internationally recognised portfolio. Today, products developed by the Lugo-based company are used in more than 40 countries worldwide, reinforcing its international presence and the confidence placed in its products by leading laboratories and institutions.
All these developments are driven by a shared vision. Under the claim “Your One Health Lab,” the AMSlab Group brings together the expertise and knowledge of all its companies to provide a multidisciplinary approach where human health, animal health, food safety, and biotechnology converge. This philosophy aligns with the internationally recognised One Health concept, which acknowledges the close interconnection between people, animals, and the environment as the foundation for addressing today’s and tomorrow’s scientific and healthcare challenges.
As Manuel Lolo, CEO of the AMSlab Group, explains:
“This evolution is the result of many years of hard work, continuous learning, and the trust of our customers and partners. We have strengthened our capabilities to continue delivering high-value solutions and to confidently address the new challenges facing the industry.”
This vision is supported by five highly specialised companies that work together to deliver comprehensive solutions across a wide range of sectors. AMSbiopharma provides analytical services for the pharmaceutical, biopharmaceutical, and chemical industries; AMSvet specialises in toxicology and analytical services for the veterinary sector; AMShealth delivers analytical solutions for clinical research; Cifga produces certified reference materials and develops biotechnology products for the agri-food, pharmaceutical, and textile industries; and Nexotech develops innovative analytical kits and solutions for both human and animal health.
Rather than operating as independent businesses, these companies form a single scientific ecosystem in which shared knowledge and interdisciplinary collaboration enable the Group to provide more comprehensive and effective solutions to its customers’ challenges.
Alongside this transformation, AMSlab is also unveiling a new corporate video that captures the essence of the Group, offering an inside look at its people, facilities, and the activities carried out by each of its companies. Through this new chapter, the AMSlab Group reaffirms its commitment to science, innovation, and the development of solutions that advance research, industry, and health.
